Clinicopathologic characteristics and prognostic factors of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study

被引:1
|
作者
Lyu, Yan-hong [1 ]
Liu, Hai-xia [2 ,3 ]
Han, Xue [4 ]
Yuan, Peng [5 ]
Wang, Ming-yi [6 ]
He, Yuan-yuan [1 ]
Ge, Jun-li [1 ]
Zou, Wei [1 ]
Jing, Ru [1 ]
Xin, Cai-shi [7 ]
Yang, Hong [1 ]
Chen, Bi-liang [1 ]
Chen, Gao-wen [8 ]
Li, Jia [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Obstet & Gynecol, 129 Changle West Rd, Xian 710032, Shaanxi, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China
[3] Liao Cheng Peoples Hosp, Dept Obstet & Gynecol, Liaocheng, Shandong, Peoples R China
[4] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning, Peoples R China
[5] Northwest Womens & Childrens Hosp, Dept Gynecol, Xian, Shaanxi, Peoples R China
[6] Gen Hosp Western Theater Command PLA, Dept Gynecol & Obstet, Chengdu, Sichuan, Peoples R China
[7] Fourth Mil Med Univ, Xian, Shaanxi, Peoples R China
[8] Southern Med Univ, Zhujiang Hosp, Obstet & Gynecol Ctr, 253 Gongye Middle Ave, Guangzhou 510282, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
high grade; mixed histology; neuroendocrine carcinoma of the cervix; perineural invasion; prognosis; treatment; HUMAN-PAPILLOMAVIRUS; CELL CARCINOMA; UTERINE CERVIX; CANCER; IMPACT; TUMORS;
D O I
10.1002/ijgo.15771
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the prognostic factors and survival outcomes of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix (NECC). Methods: This multicenter, retrospective study involved 98 cervical cancer patients with stage IA2-IIA2 and IIIC1/2p high-grade NECC. We divided the patients into two groups based on histology: the pure and mixed groups. All clinicopathologic variables were retrospectively evaluated. Cox regression and Kaplan-Meier methods were used for analysis. Results: In our study, 60 patients were in the pure group and 38 patients were in the mixed group. Cox multivariate analysis showed that mixed histology was a protective factor impacting overall survival (OS) (P = 0.026) and progression free survival (PFS) (P = 0.018) in surgically treated high-grade NECC. Conversely, survival outcomes were negatively impacted by ovarian preservation (OS: HR, 20.84; 95% CI: 5.02-86.57, P < 0.001), age >45 years (OS: HR, 4.50; 95% CI: 1.0-18.83, P = 0.039), tumor size >4 cm (OS: HR, 6.23; 95% CI: 2.34-16.61, P < 0.001), parity >3 (OS: HR, 4.50; 95% CI: 1.02-19.91, P = 0.048), and perineural invasion (OS: HR, 5.21; 95% CI: 1.20-22.53, P = 0.027). Kaplan-Meier survival curves revealed notable differences in histologic type (OS: P = 0.045; PFS: P = 0.024), chemotherapy (OS: P = 0.0056; PFS: P = 0.0041), ovarian preservation (OS: P = 0.00031; PFS: P = 0.0023), uterine invasion (OS: P < 0.0001; PFS: P < 0.0001), and depth of stromal invasion (OS: P = 0.043; PFS: P = 0.022). Conclusion: Patients with mixed histologic types who undergo surgery for high-grade NECC have a better prognosis. Meanwhile, ovarian preservation, tumor size >4 cm, parity >3, age >45 years and perineural invasion were poor prognostic predictors. Therefore, patients with high-risk factors should be considered in clinical practice.
引用
收藏
页码:1055 / 1065
页数:11
相关论文
共 50 条
  • [1] Exploring a Better Adjuvant Treatment for Surgically Treated High-grade Neuroendocrine Carcinoma of the Cervix
    Wang, Rongmin
    Xiao, Yinping
    Ma, Lingwei
    Wu, Zhiyong
    Xia, Hexia
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2023, 87 (06) : 398 - 405
  • [2] Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus
    Maru, Dipen M.
    Khurana, Hema
    Rashid, Asif
    Correa, Arlene M.
    Anandasabapathy, Sharmila
    Krishnan, Sunil
    Komaki, Ritsuko
    Ajani, Jaffer A.
    Swisher, Stephen G.
    Hofstetter, Wayne L.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (09) : 1404 - 1411
  • [3] Microscopic parametrial compromise in surgically treated high-grade neuroendocrine cervical carcinoma
    Salvo, G.
    Ramalingam, P.
    Gonzales, N. R.
    Chisholm, G.
    Frumovitz, M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 174 - 175
  • [4] High-Grade Neuroendocrine Carcinoma of the Vulva: A Clinicopathologic Study of 15 Cases
    Chen, Peter
    Euscher, Elizabeth
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1028 - 1029
  • [5] High-Grade Neuroendocrine Carcinoma of the Vulva: A Clinicopathologic Study of 15 Cases
    Chen, Peter
    Euscher, Elizabeth
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1028 - 1029
  • [6] Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications
    Wang, Kung-Liahng
    Yang, Yuh-Cheng
    Wang, Tao-Yeuan
    Chen, Jen-Ruei
    Chen, Tze-Chien
    Chen, Horng-Shen
    su, Tng-Hsien Su
    Wang, Kuo-Gon
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (02) : 209 - 216
  • [7] High-grade neuroendocrine carcinoma of the cervix -: A case report
    Baykal, C
    Al, A
    Tulunay, G
    Bulbul, D
    Güler, G
    Özer, S
    Küçükali, T
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2005, 59 (04) : 207 - 211
  • [8] Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix
    Yuan, Lei
    Jiang, Hongyuan
    Lu, Yin
    Guo, Sun-wei
    Liu, Xishi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (07) : 1315 - 1321
  • [9] Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma
    Zhang, Zhifang
    Wang, Jing
    Wu, Xiaomei
    Liu, Yuan
    Xi, Xiaowei
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (08) : 2180 - 2188
  • [10] THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE UTERINE CERVIX
    Yeni, K.
    Kim, J. H.
    Seung-hyuk, S.
    Shin-Wha, L.
    Jeong-Yeol, P.
    Dae-Yeon, K.
    Dae-Shik, S.
    Jong-Hyeok, K.
    Yong-Man, K.
    Young-Tak, K.
    Joo-Hyun, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 900 - 900